TotalMarketCap

AEON Biopharma

AEONNYSE United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$11.321 M

$0.16 -24.11%

Close of 6 Nov 2026

As of 6 Nov 2026, AEON Biopharma (AEON) has a market capitalization of $11.3M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$39.2M

Loss-making

Shares outstanding

49,882,790

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #405BiofronteraBFRI$12.0M
  2. #406Tvardi TherapeuticsTVRD$11.5M
  3. #407AEON BiopharmaAEON$11.3M
  4. #408VyomeHIND$11.3M
  5. #409Cellectar BiosciencesCLRB$11.0M

What if AEON Biopharma were worth as much as…

Open the what-if tool →

Gold $28.2T

$394,827.34

Per share 2,494,171× higher

Bitcoin $1.53T

$21,363.42

Per share 134,955× higher

Apple $5.02T

$70,134.11

Per share 443,046× higher

Or at a round number

$20.0M$50.0M$100.0M$200.0M

Where these numbers come from

Share counts and financials for AEON Biopharma are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.